Clinical case of joint detection of NRAS mutation and RET/PTC1 translocation in follicular variant of papillary thyroid cancer
https://doi.org/10.14341/serg12858
About the Authors
A. A. Golubeva
ФГБУ «НМИЦ эндокринологии» Минздрава России
Russian Federation
Russian Federation
M. V. Utkina
ФГБУ «НМИЦ эндокринологии» Минздрава России
Russian Federation
Russian Federation
S. V. Popov
ФГБУ «НМИЦ эндокринологии» Минздрава России
Russian Federation
Russian Federation
B. M. Shifman
ФГБУ «НМИЦ эндокринологии» Минздрава России
Russian Federation
Russian Federation
E. V. Bondarenko
ФГБУ «НМИЦ эндокринологии» Минздрава России
Russian Federation
Russian Federation
F. M. Abdulkhabirova
ФГБУ «НМИЦ эндокринологии» Минздрава России
Russian Federation
Russian Federation
N. M. Platonova
ФГБУ «НМИЦ эндокринологии» Минздрава России
Russian Federation
Russian Federation
References
1. Xing M. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev. 2007 Dec; 28(7):742-62. doi: https://doi.org/10.1210/er.2007-0007. Epub 2007 Oct 16. PMID: 17940185
2. Kimura ET, Nikiforova MN, Zhu Z, et al. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 2003 Apr 1; 63(7):1454-7. PMID: 12670889
3. Zou M, Baitei EY, Alzahrani AS, et al. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma. Thyroid. 2014 Aug; 24(8):1256-66. doi: https://doi.org/10.1089/thy.2013.0610. Epub 2014 Jun 10. PMID: 24798740; PMCID: PMC4106383
Review
For citations:
Golubeva A.A., Utkina M.V., Popov S.V., Shifman B.M., Bondarenko E.V., Abdulkhabirova F.M., Platonova N.M. Clinical case of joint detection of NRAS mutation and RET/PTC1 translocation in follicular variant of papillary thyroid cancer. Endocrine Surgery. 2023;17(4):35. (In Russ.) https://doi.org/10.14341/serg12858
Views:
517
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
